Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05599503 · ClinicalTrials.gov registry record · NA
SimpleC Wellness Platform With Social Robot Interaction (Long-term)
A NA study, sponsored by SimpleC.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT05599503: Completed NA study, sponsored by SimpleC.
NCT05599503 is a NA study that has completed, run by SimpleC. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05599503, a NA study, has completed, sponsored by SimpleC.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.
Primary Outcome
\[Questionnaire\] Perception and judgment of Social Assistive Robot social attributes on 3 dimensions: Warmth, competency, and discomfort
Interventions
- BEHAVIORAL Behavioral Interventions
- BEHAVIORAL Robot Interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2022-08-10 |
| Est. Completion | 2023-11-13 |
| Phase | NA |
What the finished NCT05599503 record still lists
NCT05599503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Interventions is the first listed.
NCT05599503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05599503 about?
NCT05599503 is a clinical study titled "SimpleC Wellness Platform With Social Robot Interaction (Long-term)". This study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is...
What is the current status of trial NCT05599503?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2022-08-10. Estimated completion is 2023-11-13.
What interventions are being tested in trial NCT05599503?
The interventions under investigation include: Behavioral Interventions (BEHAVIORAL), Robot Interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05599503?
This trial is sponsored by SimpleC, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05599503's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI